Page 2 - Les meilleurs doctors traitant la maladie suivante : Basaliome - TOP -50 des médecins

Le Professeur Keil se spécialise dans les techniques d'imagerie avancées pour le diagnostic précis du basaliome au Centre Médical de Solingen.

• Diplômé avec mention de l'Université Julius-Maximilians de Würzburg
• Formé sous la direction du célèbre Professeur Rolf W. Günther à Aix-la-Chapelle
• Expert en diagnostics IRM, scanner et échographie
• Médecin-chef en radiologie diagnostique depuis 2022

Spécialisé dans les traitements complets des tumeurs, y compris l'immunothérapie et le diagnostic moléculaire. Dirige un centre de cancérologie certifié à Solingen.

• Plus de 15 ans d'expérience en hématologie et oncologie
• Médecin-chef au centre d'oncologie du BKZ Solingen
• Expert en recherche de biologie moléculaire pour le cancer
• Spécialiste qualifié en génétique
• Membre des sociétés d'oncologie allemande et américaine

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Le professeur Paksoy est spécialisé en oncologie médicale, avec un accent particulier sur le basaliome, exerçant ses fonctions à l’hôpital Medipol Bahçelievler.

• Suivre une formation de spécialisation en oncologie médicale à l’Institut d’oncologie de l’université d’Istanbul
• Être certifié par l’ESMO en oncologie médicale depuis 2022
• Participer activement à de multiples essais cliniques internationaux pour divers types de cancers
• Publier de nombreux articles de recherche en oncologie, notamment sur les cancers de la peau

Le Dr Alemdar est spécialisé en oncologie médicale, ayant suivi une formation approfondie à l'Université Akdeniz, une institution de premier plan en Turquie.

• Certifié en oncologie médicale depuis 2018
• Plus de 15 ans d'expérience en médecine interne et en oncologie
• A travaillé dans plusieurs hôpitaux prestigieux, dont l'hôpital universitaire d'Akdeniz

Spécialisée en virothérapie – l'un des domaines les plus récents de l'immunologie – le Dr Jaunalksne apporte des approches de traitement de pointe.

• Plus de 30 ans d'expérience en immunologie
• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômée de l'Institut de médecine de Riga avec un internat en médecine interne

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Spécialisé dans le traitement du cancer de la peau avec une formation spécialisée au St John’s Institute of Dermatology à Londres – un leader mondial en oncologie cutanée.

• Chercheur principal en cancer de la peau aux hôpitaux Guy’s and St Thomas’
• Conférencier sur le cancer de la peau non mélanome au King’s College de Londres
• Membre de l'Académie Européenne de Dermatologie et de Vénérologie
• Formé aux techniques de chirurgie dermatologique à Tel-Aviv et à Londres

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Le Dr Bergman est un dermatologue spécialisé en oncodermatologie, se concentrant sur le diagnostic et le traitement des cancers de la peau tels que le basaliome.

• Travailler au centre médical Rambam, un hôpital israélien majeur
• Double expertise en tant que dermatologue et oncodermatologue
• Se spécialiser dans le cancer de la peau, ce qui le rend très pertinent pour les cas de basaliome

Spécialisé en oncologie radiothérapique à l'Université de Marmara – se concentre sur les traitements de précision contre le cancer.

• Certifié en oncologie radiothérapique avec des années de formation spécialisée
• Diplômé du programme de médecine en anglais de l'Université de Marmara
• Travaille au centre de traitement du cancer de l'Hôpital Emsey

Le Dr Shruti Kate est spécialisée dans les traitements avancés contre le cancer, notamment l'immunothérapie et la thérapie métronomique, au HCG Manavata Cancer Centre.

• Formée au Tata Memorial Hospital – l'un des meilleurs centres de cancérologie d'Inde
• Experte en cancers du poumon, du sein et gynécologiques
• Membre de l'ASCO, de l'ESMO et d'autres sociétés d'oncologie prestigieuses
• Présentation de travaux de recherche lors de la Conférence mondiale sur le cancer du poumon

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.